stockrowPrivia Health Group, Inc.
PRVA Healthcare Health Information Services
Privia Health Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.1 billion, up 22.3% from fiscal 2024.
- Revenue
- +13.2%
- EPS
- +83.3%
- Free cash flow
- −44.4%
Quarter to September 2026, against a year earlier
Follow PRVA
Alert me
Privia Health Group, Inc. (PRVA) Return on equity
Privia Health Group, Inc.'s return on equity over the twelve months to 30 September 2026 was 4.25%, up 1.1 percentage points from fiscal 2025 (3.11%). Over the past ten years it has ranged from −63.4% (fiscal 2021) to 24.6% (fiscal 2020); the current reading is higher than 63% of that period. That is above the Health Information Services industry median of −3.15% and above the Healthcare sector median of −26.3%.
Return on equity, annual
Embed this chart
Annual newest first
| Period | Return on equity | Change (points) |
|---|---|---|
| FY2025 | 3.11% | 0.88 |
| FY2024 | 2.23% | (1.87) |
| FY2023 | 4.10% | 5.87 |
| FY2022 | −1.77% | 61.62 |
| FY2021 | −63.4% | (88.00) |
| FY2020 | 24.6% | 18.19 |
| FY2019 | 6.42% | 6.42 |
| FY2018 | 0.00% | — |
Against its own ten years
Return on equity against peers
| Company | Return on equity |
|---|---|
| HTFL Heartflow, Inc. compare | 38.5% |
| DOCS Doximity, Inc. compare | 13.8% |
| PRVA Privia Health Group, Inc. | 4.25% |
| WAY Waystar Holding Corp. compare | 3.72% |
| GDRX GoodRx Holdings, Inc. compare | 2.52% |
| OMCL Omnicell, Inc. compare | 0.00% |
| CERT Certara, Inc. compare | −6.30% |
| TDOC Teladoc Health, Inc. compare | −11.5% |
| SDGR Schrodinger, Inc. compare | −19.0% |
| Health Information Services industry median | −3.15% |
| Healthcare sector median | −26.3% |
| Market median | 0.51% |
What Return on equity is
ROE shows how much profit a company earns for its shareholders on the equity they have in the business.
Annual: Net Income Allotted to Shareholders ÷ Average Common Equity; TTM: Net Income Allotted to Shareholders ÷ Average Common Equity (latest quarter)
More on PRVA
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement